Imbed Biosciences
PrivateLast Round
Strategic
Jan 27, 2026
Total Funding Raised
$33.19M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Imbed Biosciences is a medical device company that develops advanced synthetic therapies and antimicrobial wound matrices for the treatment of surgical wounds, burns, chronic ulcers, and soft-tissue repair.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Imbed Biosciences Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Imbed Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Jan 27, 2026 | ||||
| Convertible Debt | Jan 8, 2024 | ||||
| Debt | Dec 14, 2023 | ||||
| Debt | May 17, 2023 | ||||
| Series B | Nov 11, 2021 | ||||
Grant | Oct 14, 2021 |
Key People
Founding team and executive leadership
Imbed Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Arthritis and Musculoskeletal and Skin Diseases | Grant |
| NIH RADx | Grant |
| WISC Partners | Series A, Seed |
| Formidable Asset Management | Series A |
| Medical Technology Enterprise Consortium | Grant |
| Pegasus Tech Ventures | Convertible Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 1, 2026
Company has commercial products sold in the U.S. and overseas.
- Aug 28, 2025
Launched SAM PainGuard with Lidocaine for acute care.
Imbed Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Imbed Biosciences's valuation, stock price, and market status.